Chevron support LS9 research in synthetic hydrocarbon products

Chevron to support LS9 for research in synthetic hydrocarbon products

4:41 PM, 19th July 2011
Chevron to support LS9 for research in synthetic hydrocarbon products
Ed Dineen, President and CEO, LS9.

SOUTH SAN FRANCISCO, US: LS9 Inc will carry out a second phase of research with Chevron Technology Ventures, a division of Chevron USA Inc. This programme is directed at further improving LS9’s platform technology to produce specific pure hydrocarbon products. This second phase follows Chevron’s initial testing and evaluation of LS9’s technology solution. The terms of the funding programme were not disclosed.

“We appreciate Chevron’s continued support of LS9 and this specific technology programme. This programme will enable us to bring new fuel technologies and products to the marketplace in addition to our current UltraClean(TM) Diesel,” said Ed Dineen, President and CEO, LS9.

(C) WOC News

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


International Year of Chemistry (IYC) at halfway point

  RESEARCH TRIANGLE PARK, US: Summer is definitely here in the Northern Hemisphere, which for many means it’s time to take a break and rel ...

Read more
Newly developed fluorescent protein makes internal organs visible

BRONX, US: Researchers at Albert Einstein College of Medicine of Yeshiva University have developed the first fluorescent protein that enables scientis ...

Read more
Cadmium Selenide quantum dots release toxic ions in soil

BUFFALO, US: Quantum dots made from cadmium and selenium degrade in soil, unleashing toxic cadmium and selenium ions into their surroundings, a Univer ...

Read more
Air Products to expand nitrogen capacity in Korea

PENNSYLVANIA, US: Air Products will increase production of gaseous nitrogen and expand its nitrogen pipeline in the Gumi National Industrial Complex, ...

Read more
Lonza signs manufacturing deal with Immune Pharmaceuticals

Contract covers the clinical phase 2 production of Bertilimumab (iCo-008), a human immunoglobulin monoclonal antibody under investigation for the tr ...

Read more
Hydrogen may be key to growth of high-quality graphene

  OAK RIDGE, US: A new approach to growing graphene greatly reduces problems that have plagued researchers in the past and clears a path to the ...

Read more